EP 1144633 A1 20011017 - POLYPEPTIDE
Title (en)
POLYPEPTIDE
Title (de)
POLYPEPTID
Title (fr)
POLYPEPTIDE
Publication
Application
Priority
- EP 0000347 W 20000117
- GB 9901256 A 19990120
Abstract (en)
[origin: WO0043511A1] CASB612 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB612 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly ovarian and colon cancers, autoimmune diseases, and related conditions.
IPC 1-7
C12N 15/12; C07K 14/47; A61K 38/17; G01N 33/574; G01N 33/68; C07K 16/18; A61K 48/00
IPC 8 full level
G01N 33/50 (2006.01); A61K 31/7105 (2006.01); A61K 31/711 (2006.01); A61K 35/76 (2006.01); A61K 39/00 (2006.01); A61K 45/00 (2006.01); A61K 48/00 (2006.01); A61P 35/00 (2006.01); A61P 37/00 (2006.01); A61P 43/00 (2006.01); C07K 14/47 (2006.01); C07K 14/82 (2006.01); C07K 16/32 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12N 15/09 (2006.01); C12N 15/12 (2006.01); C12P 21/02 (2006.01); C12Q 1/02 (2006.01); C12Q 1/68 (2006.01); G01N 33/15 (2006.01); G01N 33/68 (2006.01)
CPC (source: EP US)
A61P 35/00 (2018.01 - EP); A61P 37/00 (2018.01 - EP); A61P 43/00 (2018.01 - EP); C07K 14/47 (2013.01 - EP); A61K 39/00 (2013.01 - EP US); A61K 2039/51 (2013.01 - EP)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0043511 A1 20000727; AU 2109200 A 20000807; CA 2358899 A1 20000727; CN 1344317 A 20020410; EP 1144633 A1 20011017; GB 9901256 D0 19990310; HK 1045173 A1 20021115; JP 2002534978 A 20021022
DOCDB simple family (application)
EP 0000347 W 20000117; AU 2109200 A 20000117; CA 2358899 A 20000117; CN 00805135 A 20000117; EP 00901112 A 20000117; GB 9901256 A 19990120; HK 02106796 A 20020917; JP 2000594919 A 20000117